{"topic":{"0":"Thiazolidinedione","1":"Thiazolidinedione","2":"Thiazolidinedione","3":"Thiazolidinedione","4":"Thiazolidinedione","5":"Thiazolidinedione","6":"Thiazolidinedione","7":"Thiazolidinedione","8":"Thiazolidinedione","9":"Thiazolidinedione","10":"Thiazolidinedione","11":"Thiazolidinedione","12":"Thiazolidinedione"},"dialog_lvl":{"0":"model","1":"model","2":"model","3":"model","4":"model","5":"model","6":"model","7":"model","8":"model","9":"model","10":"model","11":"model","12":"model"},"role":{"0":"Explainer","1":"Explainee","2":"Explainer","3":"Explainee","4":"Explainer","5":"Explainee","6":"Explainer","7":"Explainee","8":"Explainer","9":"Explainee","10":"Explainer","11":"Explainee","12":"Explainer"},"turn_num_tokens":{"0":12,"1":7,"2":34,"3":9,"4":13,"5":9,"6":19,"7":9,"8":33,"9":5,"10":31,"11":11,"12":30},"turn":{"0":"Hi, I'm your automated assistant. I can answer your questions about Thiazolidinedione.","1":"What are the other uses of Thiazolidinedione?","2":"Experimental investigations on TZDs have been carried out since 2005 in polycystic ovary syndrome (PCOS), non-alcoholic steatohepatitis (NASH), psoriasis, autism, ovarian hyperstimulation syndrome (by VEGF inhibition in granulosa cells), lichen planopilaris, and other conditions.","3":"Can you tell me more about the other uses?","4":"Several forms of lipodystrophy cause insulin resistance, which has responded favorably to thiazolidinediones.","5":"Are there any other interesting aspects about this article?","6":"There are some indications that thiazolidinediones provide some degree of protection against the initial stages of breast carcinoma development.","7":"Is there any other interesting information I should know?","8":"Evidence was emerging in 2008 that vitamin E with thiazolidinediones is effective in the treatment of non-alcoholic steatohepatitis due to their combined antioxidant and insulin sensitizing effects, producing histological improvements in steatosis severity.","9":"Is there anything else important?","10":"The withdrawal of troglitazone has led to concerns of the other thiazolidinediones also increasing the incidence of hepatitis and potential liver failure, an approximately 1 in 20,000 individual occurrence with troglitazone.","11":"Is there any other information you can share about the withdrawal?","12":"Because of this, the FDA recommends two to three month checks of liver enzymes for the first year of thiazolidinedione therapy to check for this rare but potentially catastrophic complication."}}